Background: Increasing reports of intrauterine device (IUD)-related abdominopelvic actinomycosis have been described recently. Surgical therapy has been the usual treatment when tubo-ovarian abscess is identified.
gram-positive anaerobic or microacrophilic rods, are normal inhabitants of the oropharynx and the bowel. The clinical syndrome of pelvic actinomycosis in association with the "modern" intrauterine device (IUD) was first reported by Henderson. z Since then, several case reports have described pelvic actinomycosis in patients with IUDs. The disease rarely occurs unless the IUD has been in place for at least 2 years, and the risk seems to increase with time. The presentation is typically indolent, often delaying the diagnosis. Endomctritis and tubo-ovarian abscess arc usually the earliest forms of pelvic actinomycosis. 4 ' The disease can spread locally and involve the ureters, bladder, and the rectum. 6 Extension to the abdominal wall, small bowel, and pelvic bones and distant hematogcnous dissemination may occur. [7] [8] [9] An initial diagnosis of ovarian or uterine tumot is frequently considered, leading to unnecessary extensive surgery. Actinomycotic pelvic abscess is treated initially by large doses of intravenously administered penicillin. Surgical intervention was necessitated in the majority of the cases previously described. 
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